Heartflow (HTFL) Research & Development (2024 - 2025)
Heartflow's (HTFL) quarterly Research & Development came in at $18.7 million in Q4 2025, up 52.01% year-on-year from $12.3 million in Q4 2024, and up 7.91% quarter-over-quarter from $17.3 million in Q3 2025.
Heartflow (HTFL) Research & Development (2024 - 2025) Analysis & Trends
Heartflow's Research & Development history runs 2 years deep, the most recent figure standing at $18.7 million for Q4 2025.
- On a quarterly basis, Research & Development rose 52.01% year-over-year to $18.7 million in Q4 2025; TTM through Dec 2025 was $63.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $64.9 million, up 49.18% from the prior year.
- Research & Development rose to $18.7 million in Q4 2025 per HTFL's latest filing, from $17.3 million in the prior quarter.
- Across five years, Research & Development topped out at $18.7 million in Q4 2025 and bottomed at $9.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 56.85 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 30.34 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 45.83 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 39.11 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 8.13 Mn |
| 10 | Heartflow | 906.97 Mn | 730.19 Mn | 39.06 Mn | 18.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 17.30 Mn |
| Jun 30, 2025 | 15.03 Mn |
| Dec 31, 2024 | 12.28 Mn |
| Sep 30, 2024 | 11.86 Mn |
| Jun 30, 2024 | 9.93 Mn |